1.3. Trifluoro ((((1-(4-(3-(6'-hydroxy-3,3'-dioxo-3',9a'-dihydro-3H-spiro[isobenzofuran-1,9' -xanthen]-6-yl)thioureido)butyl)-1H-1,2,3-triazol-4-yl)methyl)dimethylammonio)methyl)borate (2) figure 2C .
Supporting Video S4. CT of a rat bearing a puncture injury between vertebrae T7 and T8. The T7-T8 puncture injury is not visible in CT, without contrast. Video of figure 3C i-ii. The kidneys and bladder are clearly visible, but unlike in supporting videos S1 through S6, activity in the intrathecal space is not clearly resolved. Video of supporting figure S14E.
Synthetic Chemistry:
The following synthesis of a fluorescein-bearing methyl ammonium trifluoroborate 2 was performed: 1.1. General synthetic methods Chemicals were purchased from Oakwood Chemical, Aldrich, Combi-blocks, or Alfa Aesar. Fluorescein (F2456) and Fluorescein isothiocyanate isomer I (F4274) were purchased from Aldrich. Sterile, endotoxin and mycoplasma free, isotonic, 1x PBS was purchased from (pH 7.4 ± 0.1, Corning Cellgro 21-040-CM). Analytical, reverse phase UPLC-MS were performed on a Waters Acquity H class HPLC/ SQD2 mass spectrometer and a Phenomenex Kinetex 1.7μm C18 100Å, 50 cm x 2.1 mm I.D. column (00B-4475-AN), with a 1.5 min, a10-90% H 2 O:acetonitrile (ACN) (0.05% TFA) gradient and a flow rate of 0.6 mL/min (unless stated otherwise). Preparative HPLC was performed on a Agilent 1200 Series HPLC equipped on a Phenomenex Luna C18(2) 100Å, 250 cm x 21.20 mm I.D. 10 μm reverse phase column (00G-4253-P0 AX), with a 20 min, a10-90% H 2 O:ACN (0.05% TFA) gradient and a flow rate of 15 mL/min. 1 H, 13 C, and 19 F-NMR were performed on a 500 MHz Bruker spectrometer. Thermo Scientific 5 mL Reacti-Vial #13223 were used for fluoride concentration. Figure S3 . Stability assay in DMSO-1x PBS demonstrating that 2 does not lose fluoride at physiological pH. Ideally, a fluoride labeled compound should be stable in vivo. We performed an in vitro test as described by Perrin [25] [26] , to show that 2 is stable at physiological pH. 2 was placed in 50% DMSO-d6: 1x PBS solution (1:1) Supporting figure S14. SPECT attempts to image an iatrogenic anterior skull base CSF leak using [ 99m Tc]-DTPA. An intrathecal catheter was implanted into a rat (L5-L6). Its presence in the intrathecal space was confirmed by the observation of a tail-flick response. Following implantation of the catheter, an iatrogenic CSF leak was created using 22G needle. Immediately following leak generation, 100 µCi of [ 99m Tc]-DTPA was injected through the intrathecal catheter. The 22G needle was withdrawn from the nasal sinus and blood filled rhinorrhea from the left nostril was surveyed for radioactivity. Activity in rhinorrhea was confirmed. This survey took 20 min. Upon the confirming of activity in the nasal drainage, the rat was transferred to an Inveon SPECT/CT. Attempts 
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